companydata.dkGXP PHARMAID ApS: Financial statements 2024
CVR: 29615861
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. That is an increase of 12.5% compared with the year before. Equity amounted to DKK 1,096,211. The solvency ratio was 60.8%. The company had 1 employee in the financial year.
- Gross Profit
- 1,340,825 kr.
- Profit/Loss
- 216,532 kr.
- Equity
- 1,096,211 kr.
- Total Assets
- 1,802,121 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.3 mio. | 217 t. | 1.1 mio. | 1 |
| 2023 | - | 1.2 mio. | 513 t. | 880 t. | 1 |
| 2022 | - | 350 t. | -325 t. | 367 t. | 1 |
| 2021 | - | 363 t. | -504 t. | 691 t. | 2 |
| 2020 | - | 2.8 mio. | 960 t. | 1.7 mio. | 3 |
Events in 2024
GXP PHARMAID ApS has published its annual report for 2023. Gross profit came to DKK 1,192,153, and the net result was DKK 513,163.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 2 employees. In 2024, the company reported a gross profit of DKK 1,340,825 and a net result of DKK 216,532 compared with DKK 513,163 the year before. Equity amounted to DKK 1,096,211.